TRPM2 and neoplasm: Using the UALCAN database, we further validated the finding that the expression level of TRPM2 was negatively correlated with the prognosis of KIRC patients, in consideration of the tumor subtype (Figure 3G), cancer stage (Figure 3H), nodal metastasis (Figure 3I), and tumor grade (Figure 3J).